Articles

Find an Article

Filter articles

Applied Filters

Showing 1 to 10 of 90 results

The future of precision medicine part 3: translation from research to the clinic

UK, US23-10-2018Daniel Lim

The implementation of precision medicine represents a huge, possibly unprecedented, challenge to conventional clinical practice across the breadth of healthcare disciplines, says Daniel Lim of Kirkland & Ellis.

Gene-editing: a block on further development

EU22-10-2018

An EU court ruling on gene-editing regulation has sparked widespread concerns in the scientific and legal communities, as LSIPR finds.

How the EPO treats personalised healthcare patents

EU12-10-2018Laurence Gainey

The patenting of personalised healthcare inventions has proved problematic in a 
number of jurisdictions, but various aspects of these inventions are patentable in Europe, as Laurence Gainey of HGF explains.

New standards for stem cells

Costa Rica04-10-2018

Costa Rica has released new rules for the clinical investigation of adult stem cells, as María del Pilar López and Esteban Monge of Zürcher Lawyers report.

Patenting microorganisms in Mexico

Mexico05-09-2018Mariana Gonzalez-Vargas

Mexico has international depositary authority (IDA) status under the Budapest Treaty, which speeds up the patent process for microorganisms. Mariana Gonzalez-Vargas of Becerril, Coca & Becerril reviews the impact of the IDA on biotech patents in the country.

LSIPR 50 2018: Frank Kalkbrenner

Germany28-08-2018

Frank Kalkbrenner was selected in the LSIPR 50 2018 publication for​ ​his influence on the life sciences industry. He featured in the investment section, as LSIPR reports.

LSIPR 50 2018: Bryan Roberts

US27-08-2018

Bryan Roberts was selected in the LSIPR 50 2018 publication for​ ​his influence on the life sciences industry. He featured in the investment section, as LSIPR reports.

LSIPR 50 2018: Jim Tananbaum

US24-08-2018

Jim Tananbaum was selected in the LSIPR 50 2018 publication for​ ​his influence on the life sciences industry. He featured in the investment section, as LSIPR reports.

LSIPR 50 2018: Kim Nasmyth

UK03-08-2018

Kim Nasmyth was selected in the LSIPR 50 2018 publication for​ ​his influence on the life sciences industry. He featured in the business and innovation section, as LSIPR reports.

LSIPR 50 2018: Tedros Ghebreyesus

Ethiopia24-07-2018

Tedros Ghebreyesus was selected in the LSIPR 50 2018 publication for​ ​his influence on the life sciences industry. He featured in the government and policy section, as LSIPR reports.

Showing 1 to 10 of 90 results

LSIPR